- Home
- ASRT vs ANVS Comparison
ASRT vs ANVS Comparison
Compare ASRT & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASRT | ANVS |
|---|---|---|
| Founded | 1995 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 111.3M |
| IPO Year | 2004 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ASRT | ANVS |
|---|---|---|
| Price | $13.74 | $2.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $35.00 | $13.50 |
| AVG Volume (30 Days) | 45.0K | ★ 382.0K |
| Earning Date | 03-16-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.39 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $118,713,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.87 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $1.11 |
| 52 Week High | $13.90 | $5.50 |
Technical Indicators
Market Signals| Indicator | ASRT | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 72.14 | 47.01 |
| Support Level | $0.69 | $2.29 |
| Resistance Level | N/A | $2.63 |
| Average True Range (ATR) | 0.68 | 0.22 |
| MACD | 0.17 | 0.01 |
| Stochastic Oscillator | 98.27 | 34.71 |
Price Performance
Historical ComparisonAbout ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.